The present study evolved from our initial finding that CD4+ T-cell activity to myelin basic protein (MBP) in untreated MS patients ex vivo was associated with low endogenous expression of IFN-β-inducible molecules in PBMCs. Here, CD4 is linked to myeloid sarcoma.